{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:52:44Z","timestamp":1790124764300,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2012,10,15]],"date-time":"2012-10-15T00:00:00Z","timestamp":1350259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,15]],"date-time":"2012-10-15T00:00:00Z","timestamp":1350259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,9,19]]},"DOI":"10.1038\/onc.2012.451","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T09:45:02Z","timestamp":1350380702000},"page":"4565-4571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats"],"prefix":"10.1038","volume":"32","author":[{"given":"H-X","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-P","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q-J","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q-L","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,15]]},"reference":[{"key":"BFonc2012451_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFonc2012451_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng0802-339","volume":"31","author":"SS Thorgeirsson","year":"2002","unstructured":"Thorgeirsson SS, Grisham JW . Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339\u2013346.","journal-title":"Nat Genet"},{"key":"BFonc2012451_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10599","volume":"479","author":"TW Kang","year":"2011","unstructured":"Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011; 479: 547\u2013551.","journal-title":"Nature"},{"key":"BFonc2012451_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-2007-1007114","volume":"19","author":"N Fausto","year":"1999","unstructured":"Fausto N . Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis 1999; 19: 243\u2013252.","journal-title":"Semin Liver Dis"},{"key":"BFonc2012451_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M . The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 9: 749\u2013758.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012451_CR6","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/1097-0142(19950515)75:10<2420::AID-CNCR2820751006>3.0.CO;2-6","volume":"75","author":"N Livni","year":"1995","unstructured":"Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis LM et al. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer 1995; 75: 2420\u20132426.","journal-title":"Cancer"},{"key":"BFonc2012451_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1471-2180-8-133","volume":"8","author":"S Sarfraz","year":"2008","unstructured":"Sarfraz S, Hamid S, Siddiqui A, Hussain S, Pervez S, Alexander G . Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infection. BMC Microbiol 2008; 8: 133.","journal-title":"BMC Microbiol"},{"key":"BFonc2012451_CR8","first-page":"426","volume":"57","author":"MS Greenblatt","year":"1997","unstructured":"Greenblatt MS, Feitelson MA, Zhu M, Bennett WP, Welsh JA, Jones R et al. Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas. Cancer Res 1997; 57: 426\u2013432.","journal-title":"Cancer Res"},{"key":"BFonc2012451_CR9","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1172\/JCI44957","volume":"121","author":"T Kodama","year":"2011","unstructured":"Kodama T, Takehara T, Hikita H, Shimizu S, Shigekawa M, Tsunematsu H et al. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest 2011; 121: 3343\u20133356.","journal-title":"J Clin Invest"},{"key":"BFonc2012451_CR10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","volume":"134","author":"V Krizhanovsky","year":"2008","unstructured":"Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134: 657\u2013667.","journal-title":"Cell"},{"key":"BFonc2012451_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/428464a","volume":"428","author":"A Abbott","year":"2004","unstructured":"Abbott A . Laboratory animals: the Renaissance rat. Nature 2004; 428: 464\u2013466.","journal-title":"Nature"},{"key":"BFonc2012451_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature09368","volume":"467","author":"C Tong","year":"2010","unstructured":"Tong C, Li P, Wu NL, Yan Y, Ying QL . Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature 2010; 467: 211\u2013213.","journal-title":"Nature"},{"key":"BFonc2012451_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.152.3718.83","volume":"152","author":"MF Rajewsky","year":"1966","unstructured":"Rajewsky MF, Dauber W, Frankenberg H . Liver carcinogenesis by diethylnitrosamine in the rat. Science 1966; 152: 83\u201385.","journal-title":"Science"},{"key":"BFonc2012451_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0163-7258(96)00062-9","volume":"71","author":"L Verna","year":"1996","unstructured":"Verna L, Whysner J, Williams GM . N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 1996; 71: 57\u201381.","journal-title":"Pharmacol Ther"},{"key":"BFonc2012451_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/38525","volume":"389","author":"K Polyak","year":"1997","unstructured":"Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . A model for p53-induced apoptosis. Nature 1997; 389: 300\u2013305.","journal-title":"Nature"},{"key":"BFonc2012451_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, DePinho RA . Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674\u2013687.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012451_CR17","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","volume":"48","author":"P Newell","year":"2008","unstructured":"Newell P, Villanueva A, Friedman SL, Koike K, Llovet JM . Experimental models of hepatocellular carcinoma. J Hepatol 2008; 48: 858\u2013879.","journal-title":"J Hepatol"},{"key":"BFonc2012451_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/mc.2940120304","volume":"12","author":"CJ Kemp","year":"1995","unstructured":"Kemp CJ . Hepatocarcinogenesis in p53-deficient mice. Mol Carcinog 1995; 12: 132\u2013136.","journal-title":"Mol Carcinog"},{"key":"BFonc2012451_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2011.09.006","volume":"35","author":"A Kuraishy","year":"2011","unstructured":"Kuraishy A, Karin M, Grivennikov SI . Tumor promotion via injury- and death-induced inflammation. Immunity 2011; 35: 467\u2013477.","journal-title":"Immunity"},{"key":"BFonc2012451_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0092-8674(93)90461-X","volume":"74","author":"CJ Kemp","year":"1993","unstructured":"Kemp CJ, Donehower LA, Bradley A, Balmain A . Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993; 74: 813\u2013822.","journal-title":"Cell"},{"key":"BFonc2012451_CR21","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/carcin\/18.5.1027","volume":"18","author":"HE van Gijssel","year":"1997","unstructured":"van Gijssel HE, Maassen CB, Mulder GJ, Meerman JH . p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotion. Carcinogenesis 1997; 18: 1027\u20131033.","journal-title":"Carcinogenesis"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012451","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:17:05Z","timestamp":1647886625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,15]]},"references-count":21,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2013,9,19]]}},"alternative-id":["BFonc2012451"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.451","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,15]]},"assertion":[{"value":"22 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}